Multidrug resistance (MDR) is a major obstacle in cancer therapy. It results from different mechanisms; among them is P-glycoprotein (P-gp)-mediated drug efflux out of cells. The mechanism of action remains elusive. The membrane lipid surrounding of P-gp, especially cholesterol, has been postulated to play an important role. To determine the effect of cholesterol depletion on P-gp, Madin Darby canine kidney (MDCK) cells, transfected with the mdrl gene (MDR1-MDCK cells), were treated with methyl-~-cyclodextrin (MI3CD). The localization and function of P-gp were analyzed using confocal laser scanning microscopy. Treatment with 100 mM M~CD did not affect viability but altered the structural appearance of the cells and abolished efflux of rhodamine 123, a P-gp substrate. The M~3CD treatment released P-gp from intact cells into the supernatant and reduced the amount of P-gp in total membrane preparations. The P-gp was shifted from the raft fractions (1% Triton X-100, 4 ~ C) to higher density fractions in MI3CD-treated cells. The amount of cholesterol was significantly decreased in the raft fractions. Treatment of cells with 1-phenyl-2-decanoylamino-3-morpholino-l-propanol, a glucosylceramide synthase inhibitor, also led to a shift of P-gp to higher density fractions. These results show that removal of cholesterol modulates the membrane lipid composition, changes the localization of P-gp, and results in loss of P-gp function.
INTRODUCTION
The expression of multidrug resistance proteins at the bloodbrain barrier (BBB), in tumor tissue, and in T cells prevents many pharmacologically potent central nervous system, antitumor, or antihuman immunodeficiency virus drugs from reaching their target. The human muhidrug resistance (MDR1), P-glycoprotein (P-gp), belongs to the adenosine triphosphate (ATP)-binding cassette superfamily of membrane transporters. The P-gp transports compounds in an unmodified state and is therefore of particular interest for drug uptake, distribution, and elimination. It has primarily been described as a drug efflux pump, which mediates muhidrug resistance. The extent to which P-gp and other multidrug resistance proteins directly pump compounds across the plasma membrane of cells or transloeate them between the two membrane leaflets is not clear, nor is to what extent their drug transport capability is based on lipid sorting, thus influencing the physieochemical characteristics of the plasma membrane (Sharom, 1997; Roepe, 1998; Eytan and Kuchel, i999) . There is strong evidence that the lipid composition of biological membranes and the flmetion of proteins such as P-gp are closely related (Modok et al., 2004; Norris-Cervetto et al., 2004; Troost et al., 2004) .
In Madin Darby canine kidney (MDCK) cells, stably transfeeted
To whom correspondence should be addressed at E-maih kamau@ vetbio.unizh.ch with the mdrl gene (MDR1-MDCK cells), P-gp is highly expressed and homogenously distributed on the cell layer already a few days after seeding. This is in contrast to Caco-2 cell cultures that express P-gp after 2-3 wk in lower amounts and limited to patches of the cell layer (Braun et al., 2000; Hammerle et al., 2000; Tang et al., 2002) . The P-gp is primarily localized in the apical plasma membrane (Simons and Ikonen, 1997; Hammerle et al., 2000; Luker et al., 2000) , which is enriched in cholesterol, glycosphingolipids (GSLs), and sphingomyelin (SM) (Simons and van Meer, 1988; Hooper, 1999) . The MDR1-MDCK cells thus represent an ideal system to study the influence of the modulation of lipids on the localization and function of the P-gp.
The P-gp is predonfinantly localized in low-density caveolae-enriehed domains (rafts) (Lavie et al., 1998; Demeule et al., 2000; Luker et al., 2000) . To better understand the role of the lipid environment on proteins, different methods have been developed to isolate specific membrane domains (Hooper, 1999; Pike, 2003a Pike, , 2003b . Detergent-resistant rafts, prepared in cold buffer containing 1% Triton X-IO0 (Brown and Rose, 1992) , are enriched in cholesterol and GSLs (Pike, 2003a) ; hence, their role on the localization and function of P-gp is of interest.
To determine the effect of modulation of cholesterol and GSLs in MDR1-MDCK cells, cholesterol was depleted with methyl-~-cyclodextrin (Mf3CD) (Ilangumaran and Hoessli, 1998) , and the synthesis of GSLs was inhibited with 1-phenyl-2-decanoylamino-3-morpholino-l-propanolol (PDMP) (Lavie et al., 1997 (Lavie et al., , 1999 Lucci et al., 208 KAMAU ET AL. 1999; Sietsma et al., 2000; Plo et al., 2002) . The localization of Pgp and the efftux of rhodamine 123 (rho123), a P-gp substrate, in Ml3CD-treated cells were studied using confocal laser scanning microscopy (CLSM). The release of P-gp from viable cells and from total membrane preparations after M[~CD treatment was detected by immunoblotting. Lipid rafts were prepared in cold buffer containing 1% Triton X-100, from M[3CD-or PDMP-treated cells and untreated cells, and P-gp and lipid distributions in rafts and nonraft fi'actions were analyzed by immunoblotting and thin layer chromatography (TLC), respectively.
MATERIALS AND METHODS
Cell culture and treatment with MI3CD and PDMP. The MDCK cells transfi~cted with the mdrl gene (MDR1-MDCK) were a gift fi'om Ira Pastan. They were propagated in Dulbecco modified Eagle medium with Glutamax-I (Invitrogen AG, Basel, Switzerland), as described previously (Pastan et al., 1988; Hammerle et al., 2000) . The CLSM studies were performed on cell cultures grown on cell culture inserts, whereas the other experiments were performed on cell cultures grmvn in plastic culture flasks (Hannnerle et al., 2000) . In all experiments, the passage number was below 50 and unless otherwise stated, cell cultures were used 11 d after seeding, which corresponded to the stationary growth phase (Braun et al., 2000; Hammerle et al., 2000) . In the subsequent experiments, all solutions contained protease inhibitors, and the experiments were performed at least three times.
Stock solutions of 200 and 500 nv~/ M[3CD (Waeker Chemic AG, Burghausen, Gem~any) were prepared in distilled watel: Cells were incubated for 1 h in serum-free medium befin'e they were treated with 20, 30, or 100 mM MI3CD for 30 nfin, 1 h, and 2 h, respectively, at 37 ~ C. Untreated control cells were prepared sinfilarly to the Ml3CD-treated cells. The supernatants above the control and MI3CD-treated cells in the culture flasks were collected for further processing. The culture flasks were rinsed thrice with Earle's balam'~ed salt solution (EBSS) (]nvitrogen) before the cells were harvested by scraping and subsequently washed thrice with phosphate-buffered saline (PBS; 10 mM Na2HPOt-KH2PO~, 130 ntM NaCI, pH 7.4) before being processed, as indicated below.
To determine the effect of PDMR cell cultures were grmvn for 9 d before 30 IxM PDMP (Sigm~Aldrich, Buchs, Switzerland) was added in fresh medium (di Bartolomeo and Spinedi, 2001 ). The cells were incubated for 48 h at 37 ~ C, rinsed thrice with EBSS, and harvested by scraping before being used tor raft preparation as described below.
Imm~nqfluorescent labeling. The cells were p~pared for CLSM, as described previously (Pastan et al., 1988; Rothen-Rutishauser et al., 1998; Hammerle et al., 2000) . The following antibodies, diluted in PBS containing 3% (w/v) bovine serum albumin and 0.1% (w/v) saponin, were used for labeling: mouse monoclonal 4E3 anti-P-gp (Dako Diagnostics AG, Copenhagen, Denmark) 1:10, mouse monoclonal antioccludin (Zymed Laboratories Inc., San Francisco, CA) 1:100, and rabbit anticaveolin (BD Transduction Laboratories, San Jose. CA) 1:100. Anti-rabbit cyanine 3 and anti-mouse cyanine 3 (Sigma) 1:50, were used as seconda~, antibodies. F-actin was stained with Alexa Fluor 660 phalloidin 1:50 and nuclei with 1 Ixg/ml 4',6-diamidino-2-phenylindole (DAPI) (Molecular Probes, Leiden, The Netherlands). Preparations were studied with a Zeiss LSM 410 inverted microscope, and for image reconstruction, the IMARIS software (Bitplane, Zurich, Switzerland) was used (Hainmerle et al., 2000) .
The rho123 efflux assa): The efflux assay was performed, as described previously (Fontaine et al., 1996; Hammerle et al., 2000) . The efflux of rho123 (Sigma) was observed in the CLSM by z-scans of the cell layers and of the adjacent apical extracellular space. For a better orientation, the nuclei were stained using Hoechst 33342 (Molecular Probes). For P-gp inhibition studies, 0.1 mM verapamiI hydrochloride (Sigma) was added 5 rain before the addition of rho123 and Hoechst 33342 and to all solutions throughout the assay.
Viability tests. The viability of Ml~CD-treated and untreated cells was deterulined using the Live/Dead viability/cytotoxicity Kit that contained the two fluorescent probes, calcein AM and ethidium homodimer-1 (Molecular Probes). Calcein AM is cleaved by cytosolic esterases to its green fluorescent metabolite calcein in live cells, whereas ethidimu homodimer-1 permeates dead cells and stains their nuclei red (Neethling et al., 1999; Wagner et al,, 1999) . TO some of the control (;ells, 0.1 nff/ verapamil was added before staining with Live/Dead Kit to inhibit the P-gp efflux function because calcein AM is a P-gp substrate (Loor et al., 2002; Kohler and Stein, 200.3 ). An additional control, of nonviable MDR1-MDCK cells, rinsed thrice with hot EBSS, was also included in the assay. The viability of Ml3CD-treated cells was additionally tested in 96-well plates using the (3-(4,5-dimethyhhiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay (Mosmann, 1983; van de Loosdrecht et al., 1994) .
Preparation of total membranes and treatment with M~CD. Total membrane fractions were prepared, as described previously (Ilangumaran and Hoessli, 1998) . In brief, 2.5 X 10 a cells were resuspended in 5 ml of hypotonic buffer (10 n~/ Tris-HC1, 10 mM KC1, 5 mM MgClz, 1 n~l// ethylene glycolbis(aminoethylether)-tetraacetic acid, pH 7.4) and homogenized using a Dounce homogenizer (50 strokes, 1000/rain). After centrifngation at 2000 X g for 10 rain at 4 ~ C, the supernatant was layered over 5 ml of 40% (w/v) sucrose in Tris-NaCI-EDTA buffer (TNE) buffer (25 mM Tris-HCl, 150 mM NaCI, 5 mM ethylenediaminetetraacetic acid [EDTA], pH 7.4) and centrifuged at 100,000 • g for 1 h at 4 ~ C. The light scattering band containing the total membranes, above the sucrose cushion was collected and divided into four fractions, which were treated with MI3CD, as stated above, with intermittent shaking. Subsequently, the sample volumes were adjusted to 5 ml with the TNE buffer and layered over 5 ml of 40% (w/v) sucrose, and the procedure was repeated as described above. After centrifugation, the volume of the resulting membrane fractions were adjusted to 3 ml with TNE buffer, and samples centrifuged at 250,000 • g for 3.5 h at 4 ~ C-The pellets were collected and dissolved in 100 I*1 sample buffer (Laemmli, 1970) .
Differential centrifugation of cell supernatant. The supernatants from 2.5
x 10 a Ml3CD-treated and untreated cells were collected and centrifuged at 2000 x g for 10 min at 4 ~ C. The cell-free supernatants were further centrifuged at 10,000 • g for 15 rain at 4 ~ C in a $4180 rotor (Beckman Instruments). The pellets were collected and dissolved in 100 tL1 sample buffer for sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting or in 300 Ixl chloroform-methanol (2:1, v/v), for lipid analysis.
Preparation of rafts. Rafts were prepared as described previously (Brown and Rose, 1992) ; in brief, 2.5 x 10 ~ MI3CD-treated and untreated cells were lysed for 20 rain on ice in 2 ml TNE buffer containing 1% (v/v) Triton X-100 (Laemmli, 1970; Brown and Rose, 1992) . After homogenization, the homogenate was mixed with an equal volume of 80% (w/v) sucrose solution in TNE buffer and overlaid with a discontinuous sucrose gradient (2 ml each of 30, 20, 10%, and 1.5 ml of 5% [w/v] sucrose, all in TNE buffer without Triton X-IO0). After eentrifugation at 200,000 X g for 19 h at 4 ~ C, in a SW41Ti rotor (Beckman Instruments, Fullerton, CA), 1 lnl fractions were collected ti'om the top of the gradient (fractions 1-12) without including the pellet at the bottom. Raft ii"aetions 4-7 had higher optical densities (620 nm) than the rest of the fractions (Hooper, 1999) and densities of 1.06-1.13 cm :~, calculated from their respective refractive indices (refractometel; Bellingham and Stanley Inc., Tunbridge Wells, U.K.). The size intensity distribution and polydispersity factor, deternfined with a Zetasizer 3 (Malvern Instruments, Worcestershire, UK), gave the "average mean diameter" of 265.8 -+ 5.8 nm, with a mean polydispersity factor of 0.45 -+ 0.03. The distribution of protein along the gradient was characteristically skewed, with most protein being concentrated within fractions 7-12 (density range 1.13-I.20 g/enP). Each fraction was sedimented similarly to the membrane fractions and the pellets dissolved in 100/xl sample buffer for SDS-PAGE and immunoblotting.
The SDS-PAGE and immunoblots. Dissolved samples were analyzed immediately or stored at -70 ~ C. The protein concentrations were determined with the Bio-Rad D c protein assay (Bradford, 1976) . Samples were denatured by heating for 5 rain at 95 ~ C, before being loaded onto a 7.5% (w/v) gel for P-gp detection (4/xg protein/slot) or onto a 15% (w/v) gel for eaveolin detection (2 Ixg protein/slot). After SDS-PAGE and Western blotting , the antibody labeling was peKonned with the monoelonal mouse anti-human P-gp antibody C219 (Dako) or rabbit antiactin (Sigma) (1:500) or with rabbit anticaveolin antibody (1:5000). The nitrocellulose membranes were subsequently incubated with the anti-mouse (1:30,000) and anti-rabbit (1:50,000) secondary antibodies conjugated with alkaline phosphatase (Pierce Biotechnology, Rockford, IL). They were analyzed with an enhanced chemiluminescence immunoblotting detection system (BioRad Laboratories Inc., Hercules, CA).
Lipid analysis. For lipid analysis, 4.1 X 107 cells were washed and harvested by scraping, and lipids were extracted from the cell pellet using 1 ml of chloroform-methanol (2:1, v/v). Lipids were identified and quantified, as described previously (Brown and Rose, 1992; Kramer et zl., 2002) . In brief, 25 ~1 of the lipid extracts were applied onto TLC silicagel 60 aluminmn sheets (Merck, Darmstadt, Germany) together with a series of different volumes (1-25 ~1) of the reference stock solution (Shand and Noble, 1980; Kramer et al., 2002) . Polar lipids were developed with chloroform-methanolacetic acid-water (60:50:1:4, v/v), neutral lipids in heptane-diethyletheracetic acid (60:40:2, v/v), and GSLs in chloroform-methanol-water (65:25:4, v/v). The dried TLC sheets were sprayed with an aqueous solution of 3% (w/v) cupric acetate and 8% (v/v) phosphoric acid (Shand and Noble, 1980) . The dried sheets were heated for 15 rain at 180 ~ C to char the lipids. The TLC plates were scanned and subsequently analyzed by the computer program Scion Image (Scion Corp., Frederick, MD) using the macro gelplot2. The dark spots were thus converted to density peaks, which were quantified by the area under the curve (AUC). The correlation between the AUCs and the lipid concentrations of the reference spots was determined and used to calculate the concentrations of the extracted lipids (Kramer et al., 2002) .
Lipid analysis of the raft and nonraft fractions was performed on fr~ctions separated on a discontinuous sodium bromide (NaBr) gradient instead of a sucrose gradient. The homogenate was mixed with an equal volume of 64% (w/v) sodium bromide stock solution in PBS. The sample was overlaid with 2 ml of 1.73 M NaBs, 2 ml of 0.87 M NaBr (both in 0.2 M NaC1 and 0.34 nrM EDTA, pH 7.78), and 2 mI PBS. Alter centrifugation, 1-ml fractions were transferred into cellulose membrane dialysis tubes (Sigma) and dialyzed against distilled water for 8 h at room temperature. The fractions wm~ then lyophilized overnight at -20 ~ C in 20-ml, thick-walled glass bottles. The residue was transferred into 1.5-ml Eppendorf tubes containing 1 ml of" chloroform-methanol (2:1, v/v), and the tubes were placed on a shaker overnight at 4 ~ C. The superuatant containing the lipids was collected alter 5 rain centrifugation in a microfuge, and the lipids were analyzed, as indicated above.
The amount of cellular, nonesterified cholesterol in ] 00 mM Ml3CD-tweated and untreated cells was additionally determined using the Amplex | Red Cholesterol Assay Kit (Zhou et al., 1997) .
RESULTS

Localization of P-gp, caveolin, and occludin in Ml~CD-treated cells.
The CLSM showed no significant difi~rence between control cells (Fig. 1A-C ) and cells treated with 30 mM of M[3CD for 1 h (Fig. 1D-F) . In both cases, most of the P-gp was located in the apical plasma membrane of the topmost layer of cells. However, treatment with 100 nrM M[3CD for 2 h resulted in an apparent decrease of P-gp at the apical plasma membrane. The appearance of the immunolabeling was changed to a punctuate pattern, and the cells started to round up ( Fig. 1G and H) .
The localization and distribution of the raft protein caveolin and the tight-junction protein occludin were also studied using CLSM. There was no significant dill)fence between the distribution of carcolin in control ( Fig. 2A-C) and in 100 mM M[3CD-treated cells (Fig. 2D-F ). In cells treated with 100 mM M[3CD (Fig. 2J-L) , occludin was still found at the cell borders; howevel, the tight junctions appeared loosened and swollen when compared with the control cells (Fig. 2G-/) . Some intracellular labeling of occludin was also observed.
The P-gp efflux function and viability of M~CD-treated cells. Confocal microscopy showed that rho123 was effluxed to the extracellular space in control cells and in cells treated with 20 mM M[3CD for 30 rain (Fig. 3A and C) . 3)'eatment with 30 mM MI3CD fur 1 h also resulted in efflux; however, some of the rho123 was retained within the cells (Fig. 3E) . The efflux was completely inhibited by treatment with 100 mM M[3CD for 2 h (Fig. 3G) . A similar effect was observed in cells treated with verapamil, a known inhibitor of P-gp efflux activity, independent of the M[3CD treatment (Fig. 3B,  D, F, and H) .
To exclude the possibility that the loss of efflux activity after treatment with 100 mM MI3CD, which could be because of a loss of cell viability, the calcein AM-ethidium homodimer viability assay was performed. Cells remained viable after treatment with 30 and 100 nrM M[3CD for 1 and 2 h, respectively, as indicated by the green staining of cells and the lack of red nuclei ( Fig. 4D and E) . In contrast, in nonviable cells, no calcein was detected, and ethidium homodimer permeated the cells resulting in red staining of the nuclei (Fig. 4C) . The green calcein staining of control cells was stronger after verapamil incubation because the efflux of calcein AM by P-gp was inhibited ( Fig. 4A and B ) (Kohler and Stein, 2003) . The MTT assay results showed that none of the MI3CD concentrations used in our study did affect the viability of the cells. The metabolic activity of cells treated with 100 nr/V/ M[3CD remained 109 -+ 22% of the control ceils.
Effects of M~CD treatment on P-gp and caveolin in total membranes and in supernatants. Treatment of membrane fractions with
100 mM MI3CD for 2 h resulted in a significant decrease in the amount of P-gp (Fig. 5A ). In contrast, the amount of caveolin in the total membranes was not affected by M[3CD treatment.
Analysis of the supernatants of control and cells treated with 20 mM M[3CD for 30 min showed that only traces of P-gp were detected in the 10,000 • g pellets. In contrast, a substantial amount of P-gp was released after treatment of cells with 50 mM M[3CD for 30 min and to an even higher extent after treatment with 100 nrM M[3CD for 2 h (Fig. 5B ). Caveolin and actin were present in all supernatants independent of M[3CD treatment (Fig. 5B and data not shown).
Distribution of P-gp and caveolin in raft and nonrafi fractions prepared from cells treated with either M~CD or PDMP.
In control cells, there was an enrichment of P-gp in the raft fractions at a density range of 1.06-1.13 g/cm ~ (Fig. 6A) . A tendency for the distribution of P-gp over a slightly wider density range (1.06-1.15 g/cm z) was detected in cells treated with 20 mM of M[3CD for 30 rain, and treatment of cells with 100 n~/M[3CD for 2 h resulted in a significant shift of P-gp from the raft fractions to higher density ti'actions (1.18-1.20 g/cm:~). Only a small amount of P-gp remained in the raft fractions of cells treated with 100 mM M[3CD. A similar shift was also observed after treatment of ceils with PDMP for 48 h. The distribution of caveolin was not significantly affected by these treatments (Fig. 6B) .
Lipid composition of cell lysates and raft and nonrafi fractions of cells treated with either M~CD or PDMP. Glycerophospholipids
(phosphatidylsevine, PS; phosphatidylethanolanline, PE; phosphatidylcholine; and phosphatidylinositol) represented 55% (mol/mol) of total analyzed lipids in cell lysates of control cells. Cholesterol was the most abundant lipid accounting for 30%, whereas GSLs represented 9% of the total lipids (Fig. 7A) . Treatment of cells with 100 nrM M[3CD reduced the amount of cholesterol in the cell lysates to 21.4 + 4.7 nmol, which was 13.5% (mol/mol) of total analyzed lipids (Table 1) , and corresponded to 45% of the cholesterol content of control cells (47.5 +-5.4 nmol) ( Fig. 7A; Table 1 ). Results fi'om the Amplex | Red assay showed that Ml3CD-treated cells contained about 36% cholesterol of control cells.
In ratis, glycerophospholipids accounted for 49%, with PE representing 21% of the total analyzed rafts lipids. Cholesterol was the most abundant raft lipid representing 37% of analyzed raft lipids, whereas SM and GSLs accounted for 7% each (Fig. 7B and D) . Analysis of the distribution of individual lipids in the gradients showed that 70% of GSLs, 56% of SM, and 47% of cholesterol were in the 210 KAMAU ET AL. 3CD) on the localization and distribution of P-glycoprotein (P-gp) in MDR1-MDCK cells. Cells were stained for P-gp (red), actin (g~en), and nuclei (blue) and studied by confocal laser scanning microscopy. A-Hare xy-projections, ('), xz-projections, and ("), yz-projections. Arrows indicate the section levels. In B, E, and H, only P-gp and nuclei are shown for clarity, whereas C, F, and 1 are shadow projections. Most of P-gp was located in the apical membrane of both the control cells (A-C) and the cells treated with 30 mM MI3CD (D-F). Treatment of cells with 100 mM MI3CD resulted in an apparent dem~ase of P-gp (G o at the apical membrane and the residue labeling was punctuated. Figure is published in color online at http://inva'allenpress'c~176 ?request=index.htmh raft fractions (Fig. 7B and C) . There was a significant decrease in the amount of cholesterol ira the raft fractions of cells treated with 100 mM MI3CD (Fig. 7B) , and the residual cholesterol was 4.1 -+ 1.6 nmol, which corresponded to 15% (tool/tool) of the cholesterol in raft fractions of control cells (27.6 + 5.6 nmol). Instead of cholesterol, PE was the most abundant raft lipid constituting 24% of the raft lipids (Table 1) . Cholesterol was also significantly decreased in the nonraft fractions after M[3CD treatment (Fig. 7C) .
FIG. I. Effect of methyl-13-cyclodextrin (M[
The amount of GSLs in the cell lysates of PDMP-treated cells decreased significantly from 14.6 -+ 2.8 in the control cells to 4.1 -4-1.6 nmol (Fig. 7A) . The molar percentages of GSLs in the rafts and in nonraft fractions were in the same range as for the control cells ( Fig. 7B and C) . The supematant of control ceils contained 2.7 + 0.3 nmol cholesterol/rag protein and 0.2 _+ 0.1 nmol GSLs/mg protein. The lipidprotein ratio increased significantly in the supematant of ceils treated with 100 nff/M[3CD to 7.2 + 2.2 nmol/mg protein and 3.7 -+ 2.7 nmol/mg protein, respectively. (A-F, red) , occlndin (t-L, red), actin (green), and nuclei (blue). Sections and shadow projections are as indicated in Fig. 1 . There was no significant diflhrence in the distribution of caveolin between control (A-C) and in cells treated with 100 raM MI3CD (D E).
Occludin was still found in the cell [)orders of 100 nrM Ml3CD-treated cells (G-/); however, tight junctions appeared loosened, and some intracellular staining was detected. ~ Lipid and protein amounts in cell lysates, raft, and nonrafl fractions of methyl-13-cyctodextrin (M[3CD)-and PDMP-treated ceils were analyzed, and data represent the mean amounts • S.D. of ~3 independent experiments. Treatment of cells with 100 mM MI3CD resulted in decrease in amount of lipids especially in the raft fractions where the decrease was significant.
DISCUSSION
The MDR1-MDCK cells expressing high amounts of P-gp on the apical plasma membrane represented an ideal system to elucidate the mechanisms of action of the protein after modulation of membrane lipid composition. Treatment of MDR1-MDCK cells with 100 mM MI3CD reduced the amount of cholesterol in the total cell lysate, and the reduction was most significant in the raft fractions. This was accompanied by an apparent thinning out of the P-gp at the apical cell surface. Under these circumstances, efflux of rho123 was abolished, although the M[3CD-treated cells remained viable. A recent study showed that P-gp interferes with the MTT assay (Vellonen et al., 2004) ; however, the cleavage of calcein AM and the exclusion of ethidium homodimer from the nuclei of cells treated with M[~CD confirmed their viability. Our study indicates that the residual P-gp in M[~CD-treated cells was not effective for the efflux of rho123. This was consistent with previous studies, which showed that depletion of cholesterol impaired P-gp-mediated drug transport in different cell lines (Luker et al., 2000; Yunomae et al., 2003; Arima et al., 2004) . Our lipid and immunoblot analyses of the supernatant of MlSCD-treated cells showed that cholesterol depletion was accompanied by release of large amounts of P-gp together with significant amounts of GSLs from the cell surface. The release or shedding of membrane components, which includes transmembrane proteins such as P-gp, CD30 glycoprotein, and interleukin-6 receptor, after cholesterol depletion, is a phenomenon that was also reported in previous studies (Xie and Low, 1995; Ilangumaran and Hoessli, 1998; Matthews et al., 2003; Yunomae et al., 2003; Arima et al., 2004; yon Tresckow et al., 2004) . In contrast to P-gp, caveolin was present in all the supernatants independent of MI3CD treatment. When total membranes were treated with M[3CD, P-gp was also released, whereas caveolin was not.
The raft-associated proteins, influenza virus hemagglutinin and placental alkaline phosphatase, were reported to shift from the raft to the nonraft fractions after MI3CD treatment of ceils (Scheiffele et ah, 1997; Ilangumaran and Hoessli, 1998) . In these studies, the effect was tentatively related to the disorganization and loss of integrity of rafts brought about in the membrane by the removal of cholesterol.
Our study showed that the removal of cholesterol with M[3CD resulted in modulation of the lipid composition of the rafts. Cholesterol was no longer the most abundant lipid. This was accompanied by a shift of P-gp from the raft to the nonraft fractions. Caveolin localization in the rafts remained unchanged, consistent with results from previous studies (Seheiffele et al., 1997; Luker et al., 2000; Yunomae et al., 2003; Arima et al., 2004) . This indicated a clear difference in the susceptibility of P-gp and eaveolin to depletion of cholesterol. A heterogeneity in the lipid raft components in terms of their dependence on or interaction with cholesterol has been shown (Pike, 2003b) . It can, thus, be hypothesized that the difference in susceptibility between P-gp and eaveolin results from low M[~CD accessibility of cholesterol within eaveolae and a relatively high affinity between eaveolin and cholesterol (Foster et al., 2003; Magee and Parmryd, 2003) .
Investigations in our laboratory have shown that P-gp in rafts prepared from MDR1-MDCK cells have a distinct, substrate concentration-dependent ATPase activity (Bucher et al., 2005) . No activity was found in rafts prepared from M[3CD-treated cells. It remains to be demonstrated whether this loss of activity is because of the reduced amount of P-gp or cholesterol (or both) in the raft fractions, since the basal ATPase activity of P-gp reconstituted in proteoliposomes has been shown to increase on incorporation of cholesterol into the membrane (Rothnie et al., 2001; Modok et al., 2004) . Further studies will confirm whether the loss of P-gp efflux activity after depletion of cholesterol is also because of the change of the lipid composition in the vicinity of P-gp.
There was a decrease of GSLs in the total cell lysate of MDR1-MDCK cells treated with PDMP, which was consistent with results from previous studies with 3LL carcinoma and Jurkat cells (Inokuchi et al., 2000; Nagafuku et at., 2003) . Our study shows for the first time that in PDMP-treated cells, P-gp was shifted to the nonraft fractions. Similar results have been reported for the Src kinase, which is raft associated in control 3LL carcinoma ceils but shifted to the nonraft fractions after treatment with PDMP (Inokuchi et al., 2000) . Plo et al. (2002) showed that PDMP treatment also inhibits the efflux of rho123 by P-gp. In a recent study, Non'is- Cervetto et al. (2004) came to the conclusion that chemosensitization of cells expressing P-gp could not be attributed to the inhibition of glucosylceramide synthase alone. The shift of P-gp from the raft fractions shown in our study could be an explanation for the loss of efflux activity of P-gp after PDMP treatment. Caveolin localization in the rafts was not affected by the PDMP treatment, which is in line with previous observations (Naslavsky et al., 1999) .
To summarize, our study clearly showed that treatment of cells with MI3CD and PDMP resulted in compound-specific modulations of the lipid composition of the cells, and both led to a shift of P-gp from raft to nonraft fractions. Removal of cholesterol resulted in the release of P-gp and GSLs fiom the membranes of intact cells and from total membranes. These modulations of the lipid composition resulted in loss of P-gp efflux activity in viable cells.
